A Chinese herbal-medicine stock with no revenue has surged 60,000% this year. 5 things to know about the company's mysterious spike.
Shares of a little-known Chinese herbal medicine company have surged this year, with a fresh rally seeing the price quadruple in less than a week.
It's been a head-scratching move, since the company is unprofitable, and shares have moved on seemingly no news.
Regencell Bioscience Holdings, a Hong Kong-based firm specializing in traditional Chinese medicine, saw its US-listed stock soar 398% over the first two days of the week. But that move pales in comparison to the year-to-date increase, which amounted to roughly 60,000% through Tuesday's close.
The company, which offers a proprietary oral formula it says can help treat disorders like ADHD and autism, has not generated any revenue, according to a regulatory filing from October. Over the last two fiscal years, the company said it lost a combined $10.4 million.
So, what on earth is going on with this stock? Here's what to know.
1. The latest leg of the rally was triggered by a stock split
Regencell, which trades under the ticker "RGC" on the Nasdaq, soared 283% on Monday after its 38-for-1 stock split went into effect. The company originally announced the stock split on June 2.
While stock splits don't generate any value for the company — with overall market cap staying unchanged — they are often viewed as a bullish driver, since a lower per-share price can make a stock more appealing to retail investors.
Regencell finished Monday with a market cap of $30 billion, which swelled further to $39 billion at Tuesday's close. That made it — at least temporarily — worth more than more well-known companies like Lululemon, Kraft Heinz, and Reddit.
2. Retail traders are intrigued, but cautious
The rapid rise of Regencell stock was bound to catch the eye of the retail crowd, but even the enduringly bullish cohort is incredulous about what might be going on.
Though Regencell is still less talked about than flagship stocks like Tesla and Apple, users on Reddit were quick to identify the surge this week, with some speculating that Regencell was the market's newest " meme stock."
"Regencell is doing some weird stuff again," one user wrote on the subreddit r/shortsqueeze.
"I'm trying to decide if I should pull out before a possible crash," another user, who said they were a longtime investor, said on the r/pennystocks subreddit.
"I was gambling. Didn't have a clue what this company is," another user wrote on a separate thread on r/shortsqueeze about Regencell this month. "I've been watching it go the last two weeks and keep telling myself that it will crash as soon as I buy back in."
3. There's possible influence from RFK's vaccine skepticism
Regencell stock was also surging around the time Robert F. Kennedy Jr. continued his anti-vaccine push, with the Health and Human Services Secretary removing all members of the Advisory Committee on Immunization Practices last week, an independent panel that helps shape vaccination policies in the US.
ADHD or Autism Spectrum Disorder.
The formula, which is meant to be taken twice a day and aims to treat the "fundamental cause" of neurocognitive disorders, contains "only natural ingredients," the firm says.
Its website lists various herbs with qualities that can help with blood circulation, digestion, "detoxication," and other functions.
"We have not generated revenue from any TCM formulae candidates or applied for any regulatory approvals, nor have distribution capabilities or experience or any granted patents or pending patent applications and may never be profitable," the firm said in its October filing.
4. The stock has a tiny float, with most shares owned by the CEO
The company only has a small number of shares available to trade, one factor that can explain the large swings in its stock. Out of its 500 million shares, just 30 million are available for public trading. That's a far lower percentage than the average for the more widely traded stocks that populate major indexes.
Most of the company is owned by Regencell's CEO, Yat-Gai Au. He owned 86% of the company, or a $426 million stake in the first quarter, according to holdings data.
His net worth has surged to as much as $33 billion this week, according to Bloomberg, vaulting him into the ranks of the world's richest people.
Regencell's second-largest holder, Digital Mobile Venture, owned 7.6% of the company at the end of the first quarter, or around $37.5 million. RBC, BlackRock, and Morgan Stanley also owned miniscule amounts of the stock.
5. There's been controversy around shares of China- and Hong Kong-based firms
Initial public offerings from Chinese or Hong Kong-based firms have been in the spotlight recently.
A report from The Wall Street Journal this week said that more than 20 China -based companies and 17 Hong Kong-based companies that went public on the Nasdaq since 2020 have lost 50% of their value or more in a single trading day over the last two years.
In 2022, the Financial Industry Regulatory Authority issued a warning about a "heightened threat of fraud" related to small-cap companies that had recently gone public on US exchanges.
Many of the companies associated with fraud had operators based in China or broker-dealers based in Hong Kong, the regulator said.
In many cases, the broker-dealers were allocated 90% or more of the public float, Finra said, meaning they held most of the IPO shares.
The small remaining float leaves stocks vulnerable to market manipulation, it said, referring to such companies as " ramp-and-dump schemes."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 minutes ago
- Yahoo
Is Southwest Airlines Stock Underperforming the Nasdaq?
Dallas, Texas-based Southwest Airlines Co. (LUV) is a passenger airline company that provides scheduled air transportation services. Valued at a market cap of $17.8 billion, the company also provides inflight entertainment and connectivity services, and Rapid Rewards loyalty program that enables program members to earn points for dollars spent on Southwest base fares. Companies worth $10 billion or more are typically classified as 'large-cap stocks,' and LUV fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the airlines industry. The company's strengths lie in its low-cost, point-to-point business model, which allows it to operate efficiently while offering competitive fares and high flight frequency on short- to medium-haul routes. Its strong focus on customer satisfaction and operational simplicity, such as free checked bags, no change fees, and open seating policies differentiate it from many legacy carriers. 2 Outstanding Stocks Under $50 to Buy and Hold Now 3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! This airlines company has dipped 13.7% from its 52-week high of $36.12, reached on Dec. 5, 2024. Shares of LUV have declined 3.8% over the past three months, underperforming the Nasdaq Composite's ($NASX) 11.7% return during the same time frame. Moreover, on a YTD basis, shares of LUV are down 7.3%, lagging behind NASX's 1.2% uptick. Nonetheless, in the longer term, LUV has surged 9.6% over the past 52 weeks, slightly outpacing NASX's 9.4% rise over the same time frame. To confirm its bullish trend, LUV has been trading above its 200-day and 50-day moving averages since early May. On Apr. 23, LUV reported stronger-than-expected Q1 results, demonstrating resilience despite a dynamic broader economic environment, which drove its share price up by 3.7% in the following trading session. Due to higher passenger revenue, the company's total operating revenue grew 1.6% year-over-year to $6.4 billion and marginally exceeded analyst estimates. Adding to the uptick, its total operating expenses declined 1.1% from the year-ago quarter and led to a notable 63.9% decrease in its adjusted loss per share of $0.13. The bottom-line figure also exceeded the consensus estimates. LUV has outpaced its rival, Delta Air Lines, Inc.'s (DAL) 4.1% decline over the past 52 weeks and 21.4% fall on a YTD basis. Given LUV's recent underperformance, analysts remain cautious about its prospects. The stock has a consensus rating of "Hold' from the 21 analysts covering it. While the company is trading above its mean price target of $29.95, its Street-high price target of $42 represents a 34.8% premium to its current price levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
How Is United Airlines' Stock Performance Compared to Other Jets Stocks?
Chicago, Illinois-based United Airlines Holdings, Inc. (UAL) owns and manages airlines that transports people and cargos serving customers worldwide. With a market cap of $24.3 billion, the company also offers catering, ground handling, flight academy, and maintenance services for third parties. Companies worth $10 billion or more are generally described as 'large-cap stocks,' and UAL perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the airlines industry. UAL's extensive route network, strategic hubs, and loyalty program drive its competitive edge in global aviation, facilitating high-volume international and long-haul flights. The hub-and-spoke system boosts efficiency, while its MileagePlus program and partner agreements generate significant ancillary revenue. 2 Outstanding Stocks Under $50 to Buy and Hold Now 3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Despite its notable strength, UAL slipped 35.9% from its 52-week high of $116, achieved on Jan. 22. Over the past three months, UAL stock has gained 4.2%, outperforming the U.S. Global Jets ETF's (JETS) marginal loss during the same time frame. In the longer term, shares of UAL dipped 23.5% on a YTD basis, underperforming JETS' YTD losses of 14.7%. However, UAL climbed 49.9% over the past 52 weeks, outperforming JETS' 9.7% returns during the same time frame. To confirm the bullish trend, UAL has been trading above its 50-day moving average since early May. However, the stock is trading below its 200-day moving average since late March, with slight fluctuations. UAL has outperformed due to the U.S. government's plans for air traffic control upgrades and its partnership with Archer Aviation Inc. (ACHR). Additionally, UAL is partnering with JetBlue Airways Corporation (JBLU) for increased service at New York's JFK airport, offering benefits such as reciprocal loyalty perks for travelers. On Apr. 15, UAL shares closed up by 2% after reporting its Q1 results. Its adjusted EPS of $0.91 exceeded Wall Street expectations of $0.75. The company's revenue was $13.21 billion, missing Wall Street forecasts of $13.22 billion. In the competitive arena of airlines, Delta Air Lines, Inc. (DAL) has taken the lead over UAL, showing resilience with 21.4% loss on a YTD basis. However, DAL shares lagged behind the stock with a 4.1% downtick over the past 52 weeks. Wall Street analysts are bullish on UAL's prospects. The stock has a consensus 'Strong Buy' rating from the 22 analysts covering it, and the mean price target of $101.41 suggests a potential upside of 36.5% from current price levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Sign in to access your portfolio
Yahoo
9 minutes ago
- Yahoo
Is Loews Stock Outperforming the Nasdaq?
With a market cap of $18.5 billion, New York-based Loews Corporation (L) is a diversified holding company with subsidiaries operating across several industries. Its businesses include commercial property and casualty insurance through CNA Financial, offshore oil and gas drilling via Diamond Offshore Drilling, and natural gas transportation and storage through Boardwalk Pipeline Partners. Companies valued at more than $10 billion are generally considered 'large-cap' stocks, and Loews fits this criterion perfectly. Loews owns and operates a chain of 25 hotels under Loews Hotels Holding Corporation and is involved in the manufacturing of plastic containers and resins. 2 Outstanding Stocks Under $50 to Buy and Hold Now 3 ETFs with Dividend Yields of 12% or Higher for Your Income Portfolio Nvidia's Bringing Sovereign AI to Germany. Should You Buy NVDA Stock Here? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Despite this, shares of the commercial property and casualty insurance company have declined 4.4% from its 52-week high of $92.42. L stock has risen 1.6% over the past three months, lagging behind the Nasdaq Composite's ($NASX) 11.7% increase over the same time frame. In the longer term, Loews stock is up 4.3% on a YTD basis, outperforming NASX's 1.2% gain. Moreover, shares of Loews have gained 15.9% over the past 52 weeks, compared to NASX's 9.4% return over the same time frame. Despite a few fluctuations, the stock has been trading mostly above its 50-day and 200-day moving averages since last year. Shares of Loews fell 1.8% on May 5 due to a decline in Q1 2025 profit, driven largely by $97 million in catastrophe losses at its insurance unit CNA Financial, including $53 million tied to the devastating California wildfires. The company's investment income also dropped to $608 million, and net income attributable to Loews fell to $1.74 per share. In contrast, rival The Progressive Corporation (PGR) has outperformed Loews stock. PGR stock has soared 23.5% and 8.7% on a YTD basis. Despite the stock's outperformance relative to the Nasdaq over the past year, analysts remain cautiously optimistic on Loews. The stock has a consensus rating of 'Moderate Buy' from one analyst in coverage, and as of writing, L is trading below the mean price target of $217. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
